HRs and 95% CIs for selected arterial and venous thromboses among MGUS patients versus matched controls, stratified by MGUS isotype
| Type of thrombosis . | IgG/IgA MGUS . | IgM MGUS . | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1-year follow-up . | 5-year follow-up . | 1-year follow-up . | 5-year follow-up . | |||||||||
| MGUS patients (n = 2724) . | Controls (n = 10 348) . | HR* (95% CI) . | MGUS patients . | Controls . | HR* (95% CI) . | MGUS patients (n = 530) . | Controls (n = 2017) . | HR* (95% CI) . | MGUS patients . | Controls . | HR* (95% CI) . | |
| Arterial thrombosis† | 139 | 337 | 1.6 (1.3-1.9) | 359 | 1175 | 1.2 (1.1-1.4) | 24 | 91 | 1.0 (0.6-1.6) | 63 | 287 | 0.8 (0.6-1.1) |
| Venous thrombosis‡ | 35 | 32 | 4.2 (2.6-6.8) | 88 | 168 | 2.1 (1.6-2.7) | 3 | 11 | 1.0 (0.3-3.7) | 9 | 32 | 1.0 (0.5-2.2) |
| Type of thrombosis . | IgG/IgA MGUS . | IgM MGUS . | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1-year follow-up . | 5-year follow-up . | 1-year follow-up . | 5-year follow-up . | |||||||||
| MGUS patients (n = 2724) . | Controls (n = 10 348) . | HR* (95% CI) . | MGUS patients . | Controls . | HR* (95% CI) . | MGUS patients (n = 530) . | Controls (n = 2017) . | HR* (95% CI) . | MGUS patients . | Controls . | HR* (95% CI) . | |
| Arterial thrombosis† | 139 | 337 | 1.6 (1.3-1.9) | 359 | 1175 | 1.2 (1.1-1.4) | 24 | 91 | 1.0 (0.6-1.6) | 63 | 287 | 0.8 (0.6-1.1) |
| Venous thrombosis‡ | 35 | 32 | 4.2 (2.6-6.8) | 88 | 168 | 2.1 (1.6-2.7) | 3 | 11 | 1.0 (0.3-3.7) | 9 | 32 | 1.0 (0.5-2.2) |